-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on CVS Health, Lowers Price Target to $107

Benzinga·11/06/2026 01:30:42
Listen to the news
UBS analyst Kevin Caliendo maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $118 to $107.